AM
Amarantus BioScience Holdings, Inc.
AMBS · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $36.8K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.39x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 83.17%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 100.00%
Net margin 4,995.23%
Op. margin 281.13%
Quality
14 /100
Poor ROIC 4.85%
ROA 46.65%
Asset turnover 0.01x
Debt
70 /100
Low Current ratio 0.00x
Net debt/EBITDA -4.22x
Debt/Equity N/A
Stability
19 /100
Unstable Beta -4.42x
EPS volatility 679.53%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na AMBS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
John Wesley Commissiong
Employees
12
Headquarters
New York City